Better understanding of RLS and narcolepsy neurobiology
Category
Research
-
-
EAN Guideline Production Group is happy to announce the participants for the European guideline education and Cost-Conscious Healthcare (CoCoCare) programme - pilot project aimed at filling the education gap between the importance of medical guidelines for cost-effective healthcare and the fact that this matter is rarely included in medical training programs.
-
The EAN Scientific Committee met on Sunday, March 03, 2019 at the EAN Head Office in Vienna for the first time in its new configuration. The focus of the Scientific Committee (SC) for the next two years is to increase the exchanges, synergies and interactions with the Scientific Panels, that are the backbone of the European Academy of Neurology.
-
The March issue of the European Journal of Neurology is online!
-
Paper of the MonthEAN NewsFeatured Slider
Paper of the month: Does the management of status epilepticus need to be improved in Europe?
April 1, 2019For April 2019, we have selected: Kellinghaus C, Rossetti AO, Trinka E, et al. Factors predicting cessation of status epilepticus in clinical practice: Data from a prospective observational registry (SENSE). Ann Neurol 2019;85:421-432. -
Progress in understanding the genetics of epilepsies
-
Neural basis of impulse control behaviours in Parkinson’s disease
-
ResearchScientific panels reports
The importance of having a Scientific Panel on Higher Cortical Functions at EAN
March 8, 2019The Importance of having a Scientific Panel on Higher Cortical Functions in the EAN -
Nodding syndrome proved to be a tauopathy
-
The March issue of the European Journal of Neurology is online!
-
ResearchEur J Neurol
EUROPEAN JOURNAL OF NEUROLOGY – CONTRIBUTIONS FROM AUTHORS FROM THE UNITED KINGDOM
March 1, 2019Please find below articles from authors from the United Kingdom and co-authors that were published in the European Journal of Neurology. -
Paper of the MonthEAN NewsFeatured Slider
Paper of the month: Stem cell transplantation vs continued disease-modifying therapy in patients with relapsing-remitting multiple sclerosis
March 1, 2019For March 2019, we have selected: Burt RK Balabanov, MD Burman J, et al. Effect of nonmyeloablative haematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis. JAMA 2019;321(2):165-174. Stem cells are a highly topical research area in clinical neurology. Approaches vary from attempts at nerve regeneration to exploitation of immunological effects. -
Recommendations of the International Society of Intraoperative Neurophysiology for intraoperative somatosensory evoked potentials
-
The electrodiagnosis of Guillain-Barré syndrome subtypes: Where do we stand?
-
Critical review of pure autonomic failure raises awareness for early signs of Parkinson’s disease, Lewy body dementia, and Multiple System Atrophy Pure autonomic failure (PAF) is both, a rare condition and a pathogenetic mystery, first described by Bradbury and Eggleston… Continue Reading
